Proshares Trust ZBIO
ZBIO
$28.18 +1.47 (+5.50%)
At close: Oct 20, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) EPS (Diluted) (2023 - 2026)

Updated

Zenas BioPharma's EPS (Diluted) came in at -$1.77 for Q2 2026, compared with -$1.25 a year earlier.

Analysis

Zenas BioPharma (ZBIO) EPS (Diluted) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Zenas BioPharma reported EPS (Diluted) of -$7.67; for FY2025, it was -$8.44.

  • Going back by year, EPS (Diluted) was -$11.89 in FY2024 and -$24.25 in FY2023.
  • The five-year range for quarterly EPS (Diluted) is -$24.23 (Q2 2024) to $18.76 (Q3 2023).
  • Business Quant data shows ZBIO's EPS (Diluted) at -$1.46 (Q1 2026), -$5.38 (Q4 2025) and -$1.22 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.94
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.27
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.67
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.60
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Zenas BioPharma 1.77 Bn 1.10 Bn - -1.77
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.77
Mar 31, 2026 -1.46
Dec 31, 2025 -5.38
Sep 30, 2025 -1.22
Jun 30, 2025 -1.25
Mar 31, 2025 -0.80
Dec 31, 2024 -3.99
Sep 30, 2024 -5.02
Jun 30, 2024 -24.23
Mar 31, 2024 -17.89
Dec 31, 2023 -16.06
Sep 30, 2023 18.76
API Access

Zenas BioPharma EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=ZBIO&period=max&api_key=YOUR_API_KEY